Inventor · disambiguated record
Manuel F. Balandrin
Also filed as: BALANDRIN MANUEL · BALANDRIN MANUEL F
22 granted patents·7 pending applications·1,187 citations·filing 1993–2022
97Inventor score
Files withNPS PHARMA INC21AURIMMED PHARMA INC3BRIGHAM & WOMENS HOSPITAL2ARTMAN LINDA D1NBS PHARMACEUTICALS INC1
Top patents by PatentIndex Score
29 records- 0196US6211244B1Calcium receptor-active compoundsNPS PHARMA INC·Filed 1995·Granted Apr 3, 2001·251 cites·46 claims
- 0294US6011068ACalcium receptor-active moleculesBRIGHAM & WOMENS HOSPITAL·Filed 1994·Granted Jan 4, 2000·137 cites·103 claims
- 0393US6031003ACalcium receptor-active moleculesNPS PHARMA INC·Filed 1995·Granted Feb 29, 2000·151 cites·145 claims
- 0491US6313146B1Calcium receptor-active moleculesNPS PHARMA INC·Filed 1995·Granted Nov 6, 2001·104 cites·55 claims
- 0590US6383527B1Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAIDNPS PHARMA INC·Filed 1999·Granted May 7, 2002·117 cites·39 claims
- 0689US6001884ACalcium receptor-active moleculesNPS PHARMA INC·Filed 1995·Granted Dec 14, 1999·100 cites·44 claims
- 0789US5981599AInorganic ion receptor active compoundsNPS PHARMA INC·Filed 1997·Granted Nov 9, 1999·70 cites·27 claims
- 0887US6071970ACompounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseasesNPS PHARMA INC·Filed 1995·Granted Jun 6, 2000·66 cites·185 claims
- 0982US5858684AMethod of screening calcium receptor-active moleculesBRIGHAM & WOMENS HOSPITAL·Filed 1995·Granted Jan 12, 1999·59 cites·48 claims
- 1079US9212155B2Compounds advantageous in the treatment of central nervous system diseases and disordersPESYAN AMIR·Filed 2010·Granted Dec 15, 2015·3 cites·5 claims
- 1177US6710088B2Inorganic ion receptor-active compoundsNPS PHARMA INC·Filed 2002·Granted Mar 23, 2004·8 cites·26 claims
- 1274US6617358B1Anticonvulsant and central nervous system-depressing bis(fluorophenyl)alkylamides and their usesNPS PHARMA INC·Filed 2000·Granted Sep 9, 2003·7 cites·19 claims
- 1373US6589994B1Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compoundNPS PHARMA INC·Filed 1999·Granted Jul 8, 2003·27 cites·1 claims
- 1469US6342532B1Inorganic ion receptor active compoundsNPS PHARMA INC·Filed 1999·Granted Jan 29, 2002·22 cites·21 claims
- 1566US7265155B2Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compoundNBS PHARMACEUTICALS INC·Filed 2003·Granted Sep 4, 2007·4 cites·2 claims
- 1666US5506268AUse of isovaleramide as a mild anxiolytic and sedative agentNPS PHARMA INC·Filed 1993·Granted Apr 9, 1996·15 cites·15 claims
- 1763US12486218B2Compounds advantageous in the treatment of central nervous system diseases and disordersAURIMMED PHARMA INC·Filed 2022·Granted Dec 2, 2025·0 cites·8 claims
- 1862US10793515B2Compounds advantageous in the treatment of central nervous system diseases and disordersAURIMMED PHARMA INC·Filed 2015·Granted Oct 6, 2020·1 cites·14 claims
- 1959US6017965ACompounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseasesNPS PHARMA INC·Filed 1996·Granted Jan 25, 2000·21 cites·35 claims
- 2057US2003199589A1Anticonvulsant and central nervous system-depressing bis (fluorophenyl) alkylamides and their usesNPS PHARMA INC·Filed 2003·Application pending·0 cites
- 2156US6306912B1Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseasesNPS PHARMA INC·Filed 1995·Granted Oct 23, 2001·12 cites·12 claims
- 2253US6051610ACompounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseasesNPS PHARMA INC·Filed 1999·Granted Apr 18, 2000·8 cites·24 claims
- 2352US2021130285A1Novel compounds advantageous in the treatment of central nervous system diseases and disordersAURIMMED PHARMA INC·Filed 2020·Application pending·0 cites
- 2451US2006229470A1Calcium receptor-active moleculesNPS PHARMA INC·Filed 2005·Application pending·0 cites
- 2550US2013190407A1Calcium receptor-active moleculesNPS PHARMA INC·Filed 2012·Application pending·0 cites
- 2645US5763494APharmaceutical compositions comprising isovaleramideNPS PHARMA INC·Filed 1996·Granted Jun 9, 1998·4 cites·7 claims
- 2740US2004039014A1Methods and compounds for treating depression and other disordersNPS PHARMA INC·Filed 2001·Application pending·0 cites
- 2839US2006025477A1Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseasesARTMAN LINDA D·Filed 2005·Application pending·0 cites
- 2938US2006052345A1Quinazolinone compounds as calcilyticsNPS PHARMA INC·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Manuel F. Balandrin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →